These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21890868)

  • 1. Ambivalent effect of aortic stenosis on von Willebrand factor and thrombin generation. Is transvalvular gradient the guilty party?
    Le Tourneau T; Breyne J; Susen S
    Heart; 2011 Dec; 97(24):1997-8. PubMed ID: 21890868
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis.
    Natorska J; Bykowska K; Hlawaty M; Marek G; Sadowski J; Undas A
    Heart; 2011 Dec; 97(24):2023-8. PubMed ID: 21561895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of acquired von Willebrand syndrome by transcatheter aortic valve implantation.
    Marggraf O; Schneppenheim S; Daubmann A; Budde U; Seiffert M; Reichenspurner H; Treede H; Blankenberg S; Diemert P
    J Invasive Cardiol; 2014 Dec; 26(12):654-8. PubMed ID: 25480995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased bleeding risk in patients with aortic valvular stenosis: From new mechanisms to new therapies.
    Natorska J; Mazur P; Undas A
    Thromb Res; 2016 Mar; 139():85-9. PubMed ID: 26916301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalent platelet dysfunction in patients with aortic valve disease.
    Prohaska W; Zittermann A; Lüth JU; Inoue K; Köster-Eiserfunke W; Baller D; Körfer R; Kleesiek K
    J Heart Valve Dis; 2008 Sep; 17(5):542-7. PubMed ID: 18980088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heyde's syndrome without a decrease in large von Willebrand factor multimers: a case of intestinal bleedings reversed by valve replacement in a patient with aortic stenosis.
    Undas A; Windyga J; Bykowska K; Dimitrow PP; Stepien E; Sadowski J
    Thromb Haemost; 2009 Apr; 101(4):773-4. PubMed ID: 19350125
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe aortic valve stenosis and nosebleed.
    Schödel J; Obergfell A; Maass AH
    Int J Cardiol; 2007 Aug; 120(2):286-7. PubMed ID: 17150267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis.
    Yoshida K; Tobe S; Kawata M; Yamaguchi M
    Ann Thorac Surg; 2006 Feb; 81(2):490-4. PubMed ID: 16427837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand syndrome in aortic stenosis.
    Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
    N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New direction for WE thrombin.
    Berndt MC; Andrews RK
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):205-7. PubMed ID: 18216328
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty.
    Bander J; Elmariah S; Aledort LM; Dlott J; Stelzer P; Halperin JL; Kini AS; Sharma SK
    Thromb Haemost; 2012 Jul; 108(1):86-93. PubMed ID: 22627470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear-induced platelet aggregation.
    O'Brien JR
    Lancet; 1990 Mar; 335(8691):711-3. PubMed ID: 1969070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
    Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
    Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implication of gastrointestinal bleeding in degenerative aortic stenosis: an update.
    Gola W; Lelonek M
    Cardiol J; 2010; 17(4):330-4. PubMed ID: 20690087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand's disease following aortic valve replacement.
    Singh S; Klarich K; Beckman T
    J Heart Valve Dis; 2012 May; 21(3):405-6. PubMed ID: 22808848
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombin-generating capacity in patients with von Willebrand's disease.
    Rugeri L; Beguin S; Hemker C; Bordet JC; Fleury R; Chatard B; Negrier C; Dargaud Y
    Haematologica; 2007 Dec; 92(12):1639-46. PubMed ID: 18055987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the coagulation of platelet-rich plasma. Physiological mechanism and pharmacological consequences.
    Béguin S; Keularts I
    Haemostasis; 1999 Sep; 29(1):50-7. PubMed ID: 10494034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The von Willebrand factor ratio and perioperative bleeding in patients with aortic valve stenosis.
    Brandenburger C; Unislawski V; Budde U; Zittermann A; Gummert J; Knabbe C; Birschmann I
    J Cardiovasc Surg (Torino); 2019 Feb; 60(1):154-158. PubMed ID: 29532652
    [No Abstract]   [Full Text] [Related]  

  • 19. Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3?
    Favaloro EJ
    J Thromb Haemost; 2008 Mar; 6(3):545-6. PubMed ID: 18088338
    [No Abstract]   [Full Text] [Related]  

  • 20. Von Willebrand factor, factor VIII and the factor VIII/von Willebrand factor complex.
    Ingerslev J
    Dan Med Bull; 1990 Oct; 37(5):385-406. PubMed ID: 2125548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.